An interventional study of Endovascular repair of thoracoabdominal aortic aneurysm (TAAA) using branched stent graft and Endovascular repair of ascending/arch aortic aneurysm using branched stent graft in Aortic Aneurysm, Abdominal, Ascending Aorta Aneurysm and Aortic Arch Aneurysm, sponsored by University of North Carolina, Chapel Hill. Enrolling by invitation at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-04-15.
Sponsored by University of North Carolina, Chapel Hill · Not applicable, Interventional, and Other
The purpose of this study is to evaluate visceral function, after endovascular repair of thoracoabdominal aneurysms or ascending/aortic arch aneurysms.
This study will evaluate the effect of endovascular repair of thoracoabdominal aortic aneurysms (Types I-IV) on visceral function or aortic arch aneurysms using custom manufactured and off the shelf stent grafts. Specifically, the device orientation and configuration will be evaluated with respect to renal function. Since detailed CT scan imaging will be performed prior to and after endovascular repair, critical data concerning each branched vessel length, tangential orientation from the aorta, angle of incidence, and diameter can be determined. This information can then be coupled with hemodynamic data obtained from duplex ultrasonography as well as changes in renal volume, estimated glomerular filtration rate (eGFR), and flow characteristics over time. By analyzing the data in this fashion, it may be possible to determine changes in hemodynamics and/or physiologic conditions with respect to branched stent-graft design characteristics. These data may be utilized to enhance current device design and improve patient outcomes. The FDA has approved the use of commercially available devices to be used in conjunction with the investigational device if the Investigator deems this necessary.
473 studies on the registry are indexed under Aortic Aneurysm, Abdominal; 100 are open to participants now.
This study's planned enrollment of 770 is above the median of 66 across 233 interventional studies indexed under Aortic Aneurysm, Abdominal.
Browse Aortic Aneurysm, Abdominal studies →University of North Carolina, Chapel Hill is the lead sponsor of 1,340 studies on the registry; 133 are open to participants now.
Of its 155 completed or terminated interventional studies of FDA-regulated products, 136 (88%) have results posted.
Counted across the registry records on this site, refreshed daily.
Cohort 1 (TAAA) Inclusion Criteria:
Patients may be included in the study if the patient has at least one of the following and has aortic anatomy appropriate for treatment with the Zenith® p-Branch™, Zenith® t-Branch, or Physician Specified TAAA Endovascular Graft (Custom Manufactured Devices).
Aortic Aneurysm Diameter
a. TAAA (Type I - IV) (including pararenal subtypes) with orthogonal aortic diameter greater than or equal to 5 cm or b. greater than two times the normal aortic diameter
Exclusion Criteria:
General Exclusion Criteria
Patients must be excluded from the study if any of the following conditions are true:
Medical Exclusion Criteria
Patients must be excluded from the study if any of the following conditions are true:
1) Known sensitivities or allergies to stainless steel, nitinol, polyester, solder (tin, silver), polypropylene, urethane or gold 2) History of anaphylactic reaction to contrast material that cannot be adequately premedicated 3) Leaking, ruptured aneurysm associated with hypotension 4) Uncorrectable coagulopathy
Anatomical Exclusion Criteria
Patients must be excluded from the study if any of the following conditions are true:
Does not have a non-aneurysmal aortic segment proximal to the aneurysm with:
a. A length of at least 4 mm, i.e. at least 4 mm circumferential wall contact around the limits of scallop b. A diameter measured outer wall to outer wall of no greater than 31mm and no less than 21 mm; c. An angle less than 60 degrees relative to the centerline of the aneurysm; d. An angle less than 45 degrees relative to the supraceliac aorta.
Does not have visceral vessel anatomy compatible with Zenith® p-Branch™, specifically:
a. Renal vessel origins as measured relative to the superior mesenteric artery (SMA) compatible with the renal fenestration, i.e. Both renal vessel origins within 7.5mm of the corresponding renal fenestrations; b. Celiac vessel origin as measured relative to the superior mesenteric artery (SMA) compatible with the celiac scallop.
Does not have iliac artery fixation sites and anatomy consistent with:
Inability to preserve at least one hypogastric artery
-
Cohort 2 (ascending/aortic arch) Inclusion Criteria:
General Inclusion Criteria:
Patient determined to be a high-risk profile for open surgical repair considering any of the following items:
Vascular Inclusion Criteria:
Anatomic Inclusion Criteria:
1) There is enough space for the device to be deployed distal to coronary arteries and any coronary artery bypass grafts that are considered patent and necessary for proper cardiac perfusion 2) Ascending aortic length >50 mm (greater curve distance from sinotubular junction to proximal aspect of the innominate artery) 3) Sealing zone in the ascending aorta >40 mm in length and \<38 mm in diameter for native aorta (\<42 mm if surgical graft replacement in place) 4) Sealing zone in the great vessels of >20 mm in length
Diameter of CCA or subclavian artery used for sealing \< 16mm 5. Distal aortic fixation zone: Native aorta or surgical graft (endovascular device or Dacron graft) , diameter: 20-42mm, distal neck length ≥20mm 6) Access for device delivery to accommodate 22F or 24F sheath depending on device design.
7) Sealing zone in the great vessels of ≥ 20 mm in length
Extra inclusion criteria - special situations:
Aortic dissection:
If more distal disease is observed in the aorta
Exclusion Criteria:
General exclusion criteria:
Anatomic Exclusion Criteria for the Cook Ascending/Arch graft
Proximal seal site with a circumferential thrombus/atheroma/calcium
-
Endovascular repair of thoracoabdominal aortic aneurysm (TAAA) using Branched stent grafts
Device: Endovascular repair of thoracoabdominal aortic aneurysm (TAAA) using branched stent graft
Endovascular repair of aortic ascending/arch aneurysm using branched stent grafts
Device: Endovascular repair of ascending/arch aortic aneurysm using branched stent graft
Repair of thoracoabdominal aortic aneurysms
Also known as: Endovascular repair of thoracoabdominal aortic aneurysm
Repair of ascending/arch aortic aneurysms
Also known as: Endovascular repair of ascending/ arch aortic aneurysm
Change from baseline in renal function over time (up to two years) after endovascular aortic aneurysm repair various custom stent grafts
Visceral function after endovascular repair of pararenal aneurysms using various custom stent grafts. Specifically, the device orientation and configuration will be evaluated with respect to renal function over time. Critical data concerning each branched vessel from radiological studies coupled with hemodynamic data obtained from renal artery duplex, changes in renal volume, eGFR, and flow characteristics at 1, 6, 12, 18 and 24 months post procedure may make it possible to determine changes in renal function.
Time frame: Pre-procedure and 1, 6, 12, 18, and 24 months post procedure
Time to morbidity
Morbidity at 30 days, 1 \& 2 years post procedure
Time frame: 30 days and 1 & 2 years post procedure
Time to mortality
Mortality at 30 days, 1 \& 2 years post procedure.
Time frame: 30 days and 1 & 2 years post procedure
Time to loss of stent graft integrity
Evidence on contrast CT angiography of loss of stent graft integrity at 30 days, and one and two years post procedure.
Time frame: 30 days and 1 & 2 years post procedure
Time to migration
Evidence of stent graft migration on abdominal x-rays at 30 days and 1 \& 2 years.
Time frame: 30 days and 1 & 2 years post procedure
Endoleak
Evidence of Endoleak on contrast CT angiography of abdomen 30 days and 1 \& 2 years post procedure.
Time frame: 30 days and 1 & 2 years post procedure
Branch vessel Events
Evidence of branch vessel events on contrast CT angiography and renal duplex 30 days, and 1 \& 2 years post procedure.
Time frame: 30 days and 1 & 2 years post procedure
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of North Carolina, Chapel Hill